Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Endothelial-Derived Hyperpolarization Factors on 24-hr Blood Pressure Regulation Following a Bout of Prolonged Sitting

NCT07396857 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT07396857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07396857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Endothelial-Derived Hyperpolarization Factors on 24-hr Blood Pressure Regulation Following a Bout of Prolonged Sitting
Lead sponsor
Université de Sherbrooke
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 15, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular